We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTG icon
2926
B2Gold
BTG
$6.64B
$6K ﹤0.01%
2,625
-21,808
-89% -$54.2K
CNS icon
2927
Cohen & Steers
CNS
$4.3B
$6K ﹤0.01%
+184
New +$6.73K
CNTY icon
2928
Century Casinos
CNTY
$34M
$6K ﹤0.01%
+748
New +$5.16K
CRAI icon
2929
CRA International
CRAI
$1.06B
$6K ﹤0.01%
155
-1,282
-89% -$40.4K
CSWC icon
2930
Capital Southwest
CSWC
$1.6B
$6K ﹤0.01%
389
-1,150
-75% -$17.1K
CYTK icon
2931
Cytokinetics
CYTK
$10.4B
$6K ﹤0.01%
476
+253
+113% +$2.69K
DMRC icon
2932
Digimarc Corp
DMRC
$178M
$6K ﹤0.01%
+208
New +$6.49K
DNN icon
2933
Denison Mines
DNN
$2.91B
$6K ﹤0.01%
8,000
-1,200
-13% -$556
DXR icon
2934
Daxor
DXR
$59M
$6K ﹤0.01%
734
-485
-40% -$4.05K
ECC
2935
Eagle Point Credit Company
ECC
$513M
$6K ﹤0.01%
350
+209
+148% +$3.58K
ELLO icon
2936
Ellomay Capital Ltd
ELLO
$271M
$6K ﹤0.01%
700
-141
-17% -$1.13K
ENOV icon
2937
Enovis
ENOV
$1.53B
$6K ﹤0.01%
+91
New +$5.38K
ENR icon
2938
Energizer
ENR
$1.55B
$6K ﹤0.01%
141
-2,332
-94% -$106K
ERIE icon
2939
Erie Indemnity
ERIE
$13.2B
$6K ﹤0.01%
+52
New +$5.53K
EYPT icon
2940
EyePoint Inc
EYPT
$1.2B
$6K ﹤0.01%
375
-219
-37% -$4.44K
FLGT icon
2941
Fulgent Genetics
FLGT
$527M
$6K ﹤0.01%
+514
New +$4.85K
FWONK icon
2942
Liberty Media Series C
FWONK
$25.8B
$6K ﹤0.01%
177
-313
-64% -$8.97K
GLBZ
2943
DELISTED
Glen Burnie Bancorp
GLBZ
$6K ﹤0.01%
500
-61
-11% -$641
GRPN icon
2944
Groupon
GRPN
$1.02B
$6K ﹤0.01%
85
+83
+4,150% +$6.98K
GRVY
2945
GRAVITY
GRVY
$473M
$6K ﹤0.01%
1,180
+1,124
+2,007% +$5.28K
GWRS icon
2946
Global Water Resources
GWRS
$219M
$6K ﹤0.01%
625
+38
+6% +$310
H icon
2947
Hyatt Hotels
H
$16.7B
$6K ﹤0.01%
+101
New +$5.34K
HTLD icon
2948
Heartland Express
HTLD
$956M
$6K ﹤0.01%
291
-1,076
-79% -$21.6K
ICAD
2949
DELISTED
iCAD Inc
ICAD
$6K ﹤0.01%
1,788
-3,110
-63% -$11.8K
IEP icon
2950
Icahn Enterprises
IEP
$5.3B
$6K ﹤0.01%
100
– –
116 117
118
119 120

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.